FEED Business Worldwide - May, 2012
EuroChem completes acquisition of BASF fertiliser operations
German chemical group BASF has completed the sale of its fertilizers activities in Antwerp, Belgium, to EuroChem after securing antitrust approval from authorities.
The acquisition is settled at EUR830 million (US$1.1 billion). The price includes a deferred payment of around EUR130 million (US$173.5 million) to be provided between 2013 and 2016, the vendor said in a press release, adding it expected a pre-tax gain of some EUR600 million (US$800.6 million) from the sale.
The deal, wrapped up on March 31 as planned, involves plants for CAN/AN fertilisers, NPK fertilisers and nitro phosphoric acid as well as three related nitric acid plants, combining around 300 employees. The activities were carved out into a separate company, now named EuroChem Antwerpen NV.
EuroChem said in the same statement that the deal was serving its strategy to gain a bigger share of the global fertiliser market via acquisitions and organic projects.
|
|
|
Anpario Acquires Meriden Animal Health
Agricultural additives business Anpario has acquired Meriden Animal Health, a natural animal feed additive products supplier, for GBP4.125 million (US$6.56 million).
The acquisition increases Anpario's exposure to the Chinese market through Meriden's China operations, which accounted for 26% of Meriden's total sales in 2011.
Meriden supplies the global agriculture and aquaculture markets with natural animal feed additive products. Its Orego-Stim range of products, using essential oils, is the leading brand in its field and is marketed across 60 countries worldwide, with the bulk of sales outside the UK.
Meriden works with distributors in the local territories. It has a technical support team based in a representative office in Malaysia and a joint venture company in Australia. Its sales for the 12 months to December 2011 were GBP5.35 million (US$8.51 million).
Meriden will be run as a separate business enabling the team to focus on selling and marketing high quality feed additive products around the world. The two founders- Stephen Harris, managing director, and Pamela McLaren, company secretary, are to remain with the business in their existing roles, and will continue to develop the Meriden business further.
Meriden's management team will gain additional support and can benefit from working together with Anpario's research and development resource to develop new and innovative products for sale under the Meriden brand.
"Meriden Animal Health is a quality business with strong brand recognition for developing 100 percent natural feed additives. This acquisition increases our global market share in animal feed additives which is benefiting as the agriculture industry looks to use natural based solutions to promote the health and growth of animals for meat consumption," Richard Edwards, executive vice chairman of Anpario commented.
He adds, "Meriden's significant presence in China increases our involvement in the world's biggest producer of poultry and pig meat and reinforces our strategy to build more significant positions in emerging agriculture and aquaculture markets."
|
|
|
Pfizer Poultry Health acquires Alpharma, boasts widest portfolio
With the acquisition of Alpharma LLC., Pfizer Poultry Health enters the poultry nutrition sector and offers the widest portfolio of products and services among global poultry healthcare providers.
Pfizer Poultry Health gains a portfolio of medicated feed additives, water-soluble therapeutics and probiotics. These products complement Pfizer's existing range of biologicals, pharmaceuticals and devices and establish Pfizer as a full solutions provider to poultry producers.
"The integration expands Pfizer Poultry Health's product portfolio and broadens the range of healthcare solutions we can offer our poultry customers. It allows us to enter new therapeutic fields and deliver increased expertise to poultry producers," says José Francisco Ortiz C., vice president, Pfizer Poultry Health and New Established Brands.
The acquisition of Alpharma is part of Pfizer's acquisition of King Pharmaceuticals. Pfizer hopes to integrate its research and development platform with Alpharma's strong research history, leading to further advances in poultry health management for poultry producers worldwide.
|
|
|
DSM acquires Verenium's food enzymes and oilseed processing businesses
Global life sciences and materials sciences company, Royal DSM N.V. has completed the acquisition of Verenium's food enzymes and oilseed processing business at US$37 million.
The acquisition includes Verenium's oilseed processing business and IP portfolio, licenses for certain food enzymes and access to biodiversity libraries that Verenium will create using proprietary technology.
Verenium is a global leader in developing high-performance enzymes and sales of these businesses in 2012 are estimated at about US$15 million, growing rapidly in the coming years.
In fact, the annual market growth for enzymes in the global crop-based oil market is expected to be about 50% in the coming years with market potential estimated at more than US$350 million.
DSM also acquired exclusive world-wide licenses to alpha-amylase and xylanase enzymes within the food and beverage markets. The market size for food enzymes alone is more than US$1.3 billion.
With the acquisition of these assets and licenses, DSM will further strengthen its industrial biotech activities (e.g. in oilseed processing) and reinforce its food enzymes innovation pipeline.
|
|
|
The above are excerpts, full versions are only available in FEED Business Worldwide. For subscriptions enquiries, e-mail membership@efeedlink.com
